About Tablet Compare

How we decide what to include

A tablet or capsule route appears in the live comparison once it has a confirmed UK licence and a real supply route, not simply because it has been discussed in the press. Overseas approvals, trial results and waitlist pages are tracked separately in the future-pipeline guides, clearly labelled as not yet a UK buying route, until that status changes.

See the current lineup on the comparison homepage; this page covers how and why that lineup changes, not what is on it today.

How comparison information is presented

Standard public prices are shown alongside the provider and source-check date. Offers, bundles, subscriptions and discount codes are kept separate from standard price tables because their terms can differ.

Provider pages bring together public service information such as consultation, delivery and support details where it is available. Final price, stock and clinical decisions always remain with the provider.

What we do not do

• sell or prescribe medicines
• recommend a treatment for an individual
• guarantee supply, eligibility or final price
• present future medicines as current UK buying routes

Editorial and commercial standards

Some outbound provider links may be affiliate links. This does not determine whether a provider is listed, where it appears in a standard-price table or how its public information is described. We aim to correct clear errors when evidence changes.

For more detail, read the sources and methodology and editorial policy.